Preneoplastic oral lesions:: The clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression

被引:0
|
作者
Högmo, A [1 ]
Lindskog, S
Lindholm, J
Kuylenstierna, R
Auer, G
Munck-Wikland, E
机构
[1] Karolinska Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Oral Pathol, Stockholm, Sweden
[3] Karolinska Hosp, Dept Tumour Pathol, S-10401 Stockholm, Sweden
[4] Danderyd Hosp, Dept Tumour Pathol, Stockholm, Sweden
关键词
DNA; p53; p21/WAF1; leukoplakia; mouth neoplasm;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Various mucosal lesions are frequently encountered in the oral cavity. Neither macroscopic nor microscopic evaluation of these lesions gives any reliable information concerning the risk of cancer development. Material and methods: From 21 patients, 29 mucosal lesions were found to precede development of invasive squamous cell carcinoma or carcinoma in situ at the same location. The lesions were matched to 29 control lesions, with the same grade of dysplasia and from exactly the same locations but without subsequent cancer during a mean follow up of 112 months (46-194). The specimens were evaluated using Image Cytometry DNA analysis and immunohistochemical analysis of p53 and p21/WAF1 expression. Results: Lesions prior to carcinomatous development displayed a higher degree of DNA aberration as compared with the control lesions, p53 and p21/WAF1 evaluation did not reveal any differences between cases and controls. Conclusion: Image Cytometry DNA analysis is an useful adjunct to histopathological evaluation of oral mucosal lesions fbr prediction of risk of malignant transformation.
引用
收藏
页码:3645 / 3650
页数:6
相关论文
共 50 条
  • [31] LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation
    Zeng, Ping-Yao
    Berger, Shelley L.
    CANCER RESEARCH, 2006, 66 (22) : 10701 - 10708
  • [32] The interaction of taxol and vinblastine with radiation induction of p53 and p21(WAF1/CIP1)
    Tishler, RB
    Lamppu, DM
    BRITISH JOURNAL OF CANCER, 1996, 74 : S82 - S85
  • [33] Bcl-2, p21 (WAF1/CIP1) and p53 in pancreatic carcinoma
    Bruecks, A
    Saxena, A
    FASEB JOURNAL, 1998, 12 (04): : A196 - A196
  • [34] p21(Waf1/Cip1/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis
    Kuwano, K
    Kunitake, R
    Kawasaki, M
    Nomoto, Y
    Hagimoto, N
    Nakanishi, Y
    Hara, N
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (02) : 477 - 483
  • [35] Regulation of p21(WAF1/CIP1) expression by p53-independent pathways
    Zeng, YX
    ElDeiry, WS
    ONCOGENE, 1996, 12 (07) : 1557 - 1564
  • [36] p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
    Schmider, A
    Gee, C
    Friedmann, W
    Lukas, JJ
    Press, MF
    Lichtenegger, W
    Reles, A
    GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 237 - 242
  • [37] The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis
    Morrissey, JJ
    Ishidoya, S
    McCracken, R
    Klahr, S
    KIDNEY INTERNATIONAL, 1996, 49 : S83 - S87
  • [38] P21 (WAF1) expression in colorectal cancer: Correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis
    Pasz-Walczak, G
    Kordek, R
    Faflik, M
    PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (10) : 683 - 689
  • [39] Downregulation of p21/WAF1 expression by thymidylate synthase
    Kastanos, EK
    Zajac-Kaye, M
    Dennis, PA
    Allegra, CJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (02) : 195 - 200
  • [40] P21(WAF1) and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment
    Barbareschi, M
    Doglioni, C
    Veronese, S
    Bonzanini, M
    DallaPalma, P
    Harris, AL
    Caffo, O
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (12) : 2182 - 2183